Neuroblastoma
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroectodermal Tumors, Primitive
Narrower: Ganglioneuroblastoma 2
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Autologous hALK.CAR T cells for neuroblastoma | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| autologous NK cell plus GD2 antibody for neuroblastoma | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Chemotherapy + MAPK inhibitors + ARSENIC TRIOXIDE for neuroblastoma | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Magnetic Resonance Imaging + Biopsy Procedure + Bone Marrow Aspiration + Bone Marrow Biopsy + Clinical Observation + Computed Tomography + Ultrasound + ETOPOSIDE + Doxorubicin hydrochloride + Cyclophosphamide + Carboplatin for ganglioneuroblastoma | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Magnetic Resonance Imaging + Clinical Observation + Computed Tomography + Ultrasound for ganglioneuroblastoma | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.